Rice Hall James & Associates’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
2022
Q1
$368K Buy
2021
Q4
$1.1M Sell
2021
Q3
$1.63M Buy
2021
Q2
$2.1M Sell
2021
Q1
$1.96M Sell
2020
Q4
$4.33M Sell
2020
Q3
$3.96M Buy
2020
Q2
$18.6M Sell
2020
Q1
$10.7M Buy
2019
Q4
$8.84M Sell
2019
Q3
$5.82M Sell
2019
Q2
$7.23M Sell
2019
Q1
$12.7M Buy
2018
Q4
$6.75M Buy
2018
Q3
$355K Buy